Long-term toxicity and survival outcomes after stereotactic ablative radiotherapy for patients with centrally located thoracic tumors

Atalar B. , Mustafayev T., Sio T., Sahin B., Gungor G. , Aydın G. , ...More

Radiology and Oncology, 2020 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume:
  • Publication Date: 2020
  • Doi Number: 10.2478/raon-2020-0039
  • Title of Journal : Radiology and Oncology
  • Keywords: lung cancer, radiation, stereotactic ablative radiotherapy, stereotactic body radiation therapy, survival outcomes, toxicity, BODY RADIATION-THERAPY, CELL LUNG-CANCER, EARLY-STAGE, PHASE-II


Background. Stereotactic ablative radiotherapy (SABR) is effective for thoracic cancer and metastases; however, adverse effects are greater for central tumors. We evaluated factors affecting outcomes and toxicities after SABR for patients with primary lung and oligometastatic tumors.